Viva Biotech Limited is a Shanghai structure-based, integrated drug discovery platform. They serve biotechnology and pharmaceutical customers with drug discovery and development. Viva Biotech's services for early-stage drug discovery include target protein expression, structure research, hit screening, lead optimization and the determination of drug candidates.
Viva Biotech has provided drug discovery services to over 370 biotechnology and pharmaceutical customers. They have delivered 9,500 independent protein strains and assisted with over 1,000 independent drug targets.
Through Viva Biotech's Viva BioInnovator, Viva Biotech is able to identify early-stage biotech startups for Viva Biotech's invubation, equity-for-service and investment platforms.
QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Cheney Mao, Ph.D.
Founder, Chairman, Chief Executive Officer and Executive Director
Derek Ren, Ph.D.
Executive Director and President
Executive Director and CFO
Jie Wang, Ph.D.
Rongqiang Liu, Ph.D.
VP, Discovery Chemistry
Xu David, Ph.D.
Chief Business Officer
Xueheng Cheng, Ph.D.
Ying Wu, MBA
Executive Director and Executive Vice President
Zhixiong Ye, Ph.D.